Eli Lilly & Co. vs. Trevi Therapeutics, Inc. Common Stock
Eli Lilly & Co. and Trevi Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | TRVI | |
|---|---|---|
| Market Cap | $1.09 trillion | $2.53 billion |
LLY leads on 1 of 1 size & scale factors.
Valuation
| LLY | TRVI | |
|---|---|---|
| Price / Book | — | 7.86 |
LLY and TRVI split the valuation factors evenly.
Risk & Sentiment
| LLY | TRVI | |
|---|---|---|
| Short Interest | 1.29% | 0.01% |
TRVI leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, TRVI overview, TRVI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.